Table 1.
Baseline Characteristics
| Characteristics | n=111 |
|---|---|
| Hypertension, n (%) | 74 (66.7%) |
| Coronary artery disease, n (%) | 15 (13.5%) |
| Congestive heart failure, n (%) | 13 (11.7%) |
| Peripheral vascular disease, n (%) | 2 (1.8%) |
| TIA or stroke, n (%) | 16 (14.4%) |
| Obstructive sleep apnea, n (%) | 24 (21.6%) |
| Chronic kidney disease, n (%) | 3 (2.7%) |
| Diabetes | 16 (14.4%) |
| Female, n (%) | 50 (45.0%) |
| Age, mean±SD, y | 65±11 |
| BMI, mean±SD, kg/m2 | 29±6 |
| Fitzpatrick skin tone n, (%) | |
| I | 10 (9.0%) |
| II | 17 (15.3%) |
| III | 42 (37.8%) |
| IV | 26 (23.4%) |
| V | 11 (9.9%) |
| VI | 5 (4.5%) |
| Black/African American, n (%) | 13 (11.7%) |
| CHA2DS2‐VASc score, mean±SD | 2.6±1.6 |
| History of atrial fibrillation ablation, n (%) | 2 (1.8%) |
| Antiplatelet therapy, n (%) | 2 (1.8%) |
| Oral anticoagulants, n (%) | 18 (16.2%) |
BMI indicates body mass index; and TIA, transient ischemic attack.